Overview

Deslorelin is a synthetic gonadotropin-releasing hormone (GnRH) agonist, formulated as a biocompatible subcutaneous implant that releases the drug continuously over many months. Although initially developed to induce ovulation in mares, it has become the veterinary standard of care for medical management of adrenocortical disease in ferrets. Continuous GnRH receptor stimulation paradoxically downregulates the pituitary-gonadal axis, suppressing luteinizing hormone (LH) — the hormone that drives the abnormal adrenal sex steroid production characteristic of ferret adrenal disease.

In ferrets, deslorelin has largely replaced monthly leuprolide injections because a single implant typically controls signs for 12-24 months (often longer), is well tolerated, and avoids the stress and cost of repeat injections.

Uses

The primary indication in ferrets is adrenocortical disease, where deslorelin improves or resolves:

  • Symmetric alopecia
  • Vulvar swelling in spayed females
  • Prostatic enlargement in neutered males
  • Pruritus and fragile skin
  • Aggression and mating behaviors
  • Muscle wasting and lethargy

Deslorelin is also used in other species as a reversible chemical sterilant for dogs and for behavioral management in several exotic species, though those uses are outside the ferret scope of this article.

Dosage

Deslorelin is supplied as a preloaded implanter:

  • Suprelorin F (4.7 mg) is the most commonly used strength in ferrets, implanted subcutaneously between the shoulder blades
  • Duration of effect is typically 12-24 months; some ferrets benefit for longer
  • The 9.4 mg implant provides longer duration in some ferrets
  • Reimplantation is performed when clinical signs recur

Placement is often done during a brief sedation or under light anesthesia, though some clinicians perform it awake in cooperative ferrets using only a local block.

Side Effects

Deslorelin is generally very well tolerated. Reported effects include:

  • Mild local reaction at the implant site
  • Transient “flare” effect in the first 1-2 weeks, with possible brief worsening of signs before suppression takes hold
  • Rarely, no response (failure to suppress signs)
  • Theoretical concern about adrenal tumor progression independent of LH signaling

Drug Interactions

  • Concurrent prednisolone (for insulinoma) is very common and compatible
  • Deslorelin may lower endogenous cortisol slightly, which can unmask or worsen hypoglycemia in ferrets with insulinoma — monitor blood glucose after implantation
  • No significant interactions with anesthetics, antibiotics, or gastroprotectants

Contraindications

  • Pregnant animals (not relevant in neutered pet ferrets)
  • Intact breeding ferrets where fertility is desired
  • Known hypersensitivity to GnRH analogs
  • Use caution in ferrets with severe concurrent insulinoma; monitor glucose closely

FAQs

How quickly will I see improvement? Hair regrowth usually begins within 4-8 weeks, and vulvar swelling or aggressive behavior typically resolves within 2-4 weeks.

Does deslorelin cure adrenal disease? No. It suppresses the hormonal drive but does not eliminate the adrenal tumor or hyperplasia. Ultrasound-visible masses remain.

Can the implant be removed? Removal is difficult and not usually necessary, as the drug simply wears off over time.

How often does it need to be replaced? Typically every 12-24 months, guided by recurrence of clinical signs.

Is surgery still an option? Yes. Adrenalectomy remains an option, particularly for unilateral masses, and can be curative. Many owners choose deslorelin because it is less invasive.